Crispr Therapeutics Ag · NASDAQ:CRSP

Kulkarni Samarth sold 47,837 Crispr Therapeutics Ag shares (Form 4)

Traded Oct 16 to Oct 19, 2026 · Filed Oct 20, 2026

From Oct 16 to Oct 19, 2026, Kulkarni Samarth (Director, Chief Executive Officer) sold 47,837 Crispr Therapeutics Ag shares at US$49.78 for US$2.38M, leaving 311,899 shares. Filed Oct 20, 2026 (Form 4).

Sold: 47,837 shares
Price: US$49.78
Value: US$2.38M
Holding after: 311,899 shares
Trading plan: No
Role: Director, Chief Executive Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 16, 2026	Common Shares	Option exercise	100,000		359,736	Direct
Oct 19, 2026	Common Shares	Sale	47,837	US$49.78	311,899	Direct

Source

Download original · View original at SEC

Related